Transcutaneous Spinal Cord Stimulation for Parkinson Disease
NCT ID: NCT04171076
Last Updated: 2019-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
5 participants
INTERVENTIONAL
2019-10-15
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Spinal Cord Stimulation on Gait in Patients With Parkinson´s Disease
NCT05148468
Spinal Cord Stimulation for Gait Disorders in Parkinson's Disease
NCT04682678
Spinal Cord Stimulation for Gait in Parkinson Disease
NCT03079310
Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease
NCT06630702
Spinal Cord Stimulation for Parkinson's Disease Rehabilitation
NCT06804642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Intervention: non-invasive spinal cord stimulation
Transcutaneous spinal cord stimulation
Theta burst stimulation at thoracic level (T5) over 2 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous spinal cord stimulation
Theta burst stimulation at thoracic level (T5) over 2 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* significant freezing of gait despite optimized treatment with medications and rehabilitation program
Exclusion Criteria
* dementia
* cardiac pacemaker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rubens Gisbert Cury
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of São Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USaoPauloGH 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.